Using the drugs currently prescribed for schizophrenia or bipolar disorder ... companions about Merck’s development of ...

He was so struck by the effect on his patients, especially with a drug called chlorpromazine (trade ... Smith Kline put it on the market as an anti-vomiting treatment. But word of the French ...

British drug companies are making a new assault on schizophrenia, with about 16 novel medicines in the pipeline. A number of experimental drugs are designed to alter the chemistry of brain regions ...

Society still treats those with psychosis, including schizophrenia ... this deinstitutionalization is possible because of anti-psychotic drugs, which allow many psychotic patients to live more ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

Is The Schizophrenia Drugs Market Set To Witness Substantial Growth? A notable rise in the global schizophrenia drugs market is evident. From $7.96 billion in 2024, the schizophrenia drugs market ...

But the medicines are also linked to a lower risk of drug and alcohol addiction, psychotic disorders such as schizophrenia ... think about how well anti-obesity drugs work.

Cahalan had anti-NMDAR encephalitis ... Several clinical trials have tested whether various immunomodulatory drugs can improve the symptoms of schizophrenia. In one recently published study, ...

For Boehringer, the deal adds to a broad pipeline in schizophrenia that spans both pharmacological and digital therapeutic (DTx) products. Leading the charge for new drug therapies is iclepertin ...